Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer
Clinical trial NCT03818282 · UNKNOWN
Trial details
- NCT number
- NCT03818282
- Sponsor
- Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2023-06-30
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.